Teaching R effectively is just the starting point for lasting adoption in pharma. At GSK, we began by developing two core R courses written in bookdown and delivered interactively, an approach that enabled high completion rates.

Recognizing that training alone isn't enough, we expanded support through options like self-certification, intermediate courses, and a Resource Hub. We also launched AccelerateR to provide tailored support to early adopters during their transition.

Today, those efforts have scaled and evolved into Rburst, a cross-functional initiative designed not just to teach R, but to embed it into our ways of working across all of Biostatistics. 

This talk will explore how our training strategy has matured into a broader support model, enabling wide-scale, integrated adoption of R in everyday work.
Alanah Jonas
GSK
Beyond Training: Evolving Strategies to Teach and Support R Adoption in Pharma
Teaching R effectively is just the starting point for lasting adoption in pharma. At GSK, we began by developing two core R courses written in bookdown and delivered interactively, an approach that enabled high completion rates.    Recognizing that training alone isn't enough, we expanded support through options like self-certification, intermediate courses, and a Resource Hub. We also launched AccelerateR to provide tailored support to early adopters during their transition.    Today, those efforts have scaled and evolved into Rburst, a cross-functional initiative designed not just to teach R, but to embed it into our ways of working across all of Biostatistics.     This talk will explore how our training strategy has matured into a broader support model, enabling wide-scale, integrated adoption of R in everyday work.